Wu JT - Search Results

1

[Medication versus health education for patients with type Ⅲ prostatitis-like symptoms: A prospective randomized control study].

Liao XH, Chen JQ, Wu JT, Cheng JL, Wang F. Liao XH, et al. Among authors: wu jt. Zhonghua Nan Ke Xue. 2019 May;25(5):420-423. Zhonghua Nan Ke Xue. 2019. PMID: 32216227 Clinical Trial. Chinese.

2

CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Li Z, Xie J, Wu J, Li W, Nie L, Sun X, Tang A, Li X, Liu R, Mei H, Wang F, Wang Z, Gui Y, Cai Z. Li Z, et al. PLoS One. 2014 Feb 28;9(2):e88965. doi: 10.1371/journal.pone.0088965. eCollection 2014. PLoS One. 2014. PMID: 24586462 Free PMC article.

3

Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.

Yang J, Liu Y, He A, Liu Y, Wu J, Liao X, Lv Z, Wang F, Mei H. Yang J, et al. Oncotarget. 2017 Aug 3;8(40):68721-68729. doi: 10.18632/oncotarget.19878. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978151 Free PMC article.

4

Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.

Liao X, Chen J, Liu Y, He A, Wu J, Cheng J, Zhang X, Lv Z, Wang F, Mei H. Liao X, et al. Cancer Biomark. 2018 Feb 6;21(2):277-285. doi: 10.3233/CBM-170354. Cancer Biomark. 2018. PMID: 29226855

5

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis.

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H. Liu Y, et al. Onco Targets Ther. 2018 Mar 1;11:1121-1139. doi: 10.2147/OTT.S154211. eCollection 2018. Onco Targets Ther. 2018. PMID: 29535537 Free PMC article. Review.

6

CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer.

Zhang Z, Chen J, Zhu Z, Zhu Z, Liao X, Wu J, Cheng J, Zhang X, Mei H, Yang G. Zhang Z, et al. Front Mol Biosci. 2021 Jan 18;7:627774. doi: 10.3389/fmolb.2020.627774. eCollection 2020. Front Mol Biosci. 2021. PMID: 33537343 Free PMC article.

7

Targeted Methylation of the LncRNA NEAT1 Suppresses Malignancy of Renal Cell Carcinoma.

Chen J, Liao X, Cheng J, Su G, Yuan F, Zhang Z, Wu J, Mei H, Tan W. Chen J, et al. Front Cell Dev Biol. 2021 Dec 9;9:777349. doi: 10.3389/fcell.2021.777349. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34957107 Free PMC article.

8

Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma.

Xie J, Zhu C, Wu J, Li C, Luo L, Xia L, Li X, Gui Y, Cai Z, Li Z. Xie J, et al. Oncotarget. 2016 Feb 9;7(6):6824-34. doi: 10.18632/oncotarget.6829. Oncotarget. 2016. PMID: 26758419 Free PMC article.

9

Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation.

Luo L, Wu J, Xie J, Xia L, Qian X, Cai Z, Li Z. Luo L, et al. Tumour Biol. 2016 Jan;37(1):1121-9. doi: 10.1007/s13277-015-3913-1. Epub 2015 Aug 15. Tumour Biol. 2016. PMID: 26276361

10

Modification of the RpoS network with a synthetic small RNA.

Jin Y, Wu J, Li Y, Cai Z, Huang JD. Jin Y, et al. Nucleic Acids Res. 2013 Sep;41(17):8332-40. doi: 10.1093/nar/gkt604. Epub 2013 Jul 9. Nucleic Acids Res. 2013. PMID: 23842672 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

822 results

Search Page

Filters